Oncology

A Wealth of Experience

We have collaborated with our clients on projects to research cancer, cancer treatment, and complications and comorbidities of cancer. Our experience includes:

  • Basal cell carcinoma
  • Bladder cancer
  • Breast cancer
  • Cervical cancer
  • Colorectal cancer
  • Endometrial cancer
  • Gastric cancer
  • Glioblastoma multiforme
  • Head and neck cancer
  • Large B-cell lymphoma
  • Leukemia
  • Liver cancer
  • Lung cancer
  • Melanoma
  • Myelofibrosis
  • Neuroendocrine tumors
  • Non-Hodgkin’s lymphoma
  • Renal cell carcinoma
  • Osteosarcoma
  • Ovarian cancer
  • Pancreatic cancer
  • Peritoneal cancers
  • Prostate cancer
  • Thyroid cancer

Types of Projects

We have implemented studies to help our clients develop strategies in the oncology market and to develop and gain 
market access for products to treat cancer and complications arising from treatment of cancer illnesses. 

Recent projects have included:

Our Experts

Jessica Costello
Senior Associate, Market Access and Outcomes Strategy
Keith Davis
Senior Director, Health Economics
Ryan Ziemiecki
Director, Biostatistics
Kelly Hollis
Vice President, Surveys and Observational Studies
Ann Colosia
Associate Director, Market Access and Outcomes Strategy
Annete Njue
Director, Market Access and Outcomes Strategy
Michele Wilson
Director, Health Economics
Marci Clark
Director, Patient-Centered Outcomes Assessment
Costel Chirila
Director, Biostatistics
Lori McLeod
Vice President, Patient-Centered Outcomes Assessment
Sorrel Wolowacz
Head, European Health Economics
Dee Dee Mladsi
Head, Health Economics-Strategy and Early Modeling
Katherine Houghton
Director, Health Economics
Donald Stull
Head, Data Analytics and Design Strategy
Sean Candrilli
Head, Health Economics
Carol Mansfield
Senior Research Economist
Christine Poulos
Senior Research Economist
Joan Fortuny
Director, Epidemiology
Shaun Abeysinghe
Senior Director, Data Analytics and Design Strategy
Juliana Meyers
Director, Health Economics
Brett Hauber
Senior Economist and VP, Health Preference Assessment
Chris Knight
Senior Director, Health Economics
Lynda Doward
European Head, Patient-Centered Outcomes Assessment
Kati Copley-Merriman
Vice President, Market Access and Outcomes Strategy
Bintu Sherif
Director, Biostatistics
Elizabeth Andrews
Vice President, Pharmacoepidemiology and Risk Management
Carla DeMuro
Executive Director, Patient-Centered Outcomes Assessment
Lia Gutierrez
Senior Director, Epidemiology
Melissa Juniper
Senior Director, Market Access and Outcomes Strategy
Will Herring
Director, Health Economics
Dawn Odom
Vice President, Head, Biostatistics
Kenneth Rothman
Distinguished Fellow, Vice President of Epidemiology Research
Stephanie Barrows
Senior Director, Market Access and Outcomes Strategy
Marco Boeri
Senior Research Economist
Jianmin Wang
Director, Biostatistics, US
Xiaolei Zhou
Director, Biostatistics
James Kaye
Senior Director, Epidemiology
Beth Sherrill
Vice President, Biostatistics
Shahnaz Khan
Executive Director, Market Access and Outcomes Strategy
Jonathan Graham
Director, Health Economics
Jin Yang
Senior Associate, Market Access and Outcomes Strategy
Caroline Ling
Senior Director, Market Access and Outcomes Strategy
Alicia Gilsenan
Senior Director, Epidemiology
Colleen Castro
Senior Associate, Market Access and Outcomes Strategy
Katherine Hicks
Director, Health Economics
Isobel Pearson
Director, Health Economics, Health Technology Assessment
Mark Price
Senior Director, Surveys and Observational Studies
Anita Brogan
Head, Decision Analytic Modeling, US Health Economics
Christopher Graham
Senior Director, Health Economics
Anne Heyes
Executive Director, Market Access and Outcomes Strategy, Europe

Selected Recent Oncology Publications